Beetham Thomas W. has filed 9 insider transactions across 1 company since September 2024.
Most recent transaction: a tax payment of 3048 shares of Viridian Therapeutics, Inc.\DE ($VRDN) on March 03, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | F | Common Stock | 3048 | $30.19 | 13,361.0000 | 95,442,008 | 18.58% | 0.00% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | M | Restricted Stock Units | 9409 | $0.00 | 28,227.0000 | 95,442,008 | 25.00% | 0.01% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | F | Common Stock | 3138 | $29.32 | 13,271.0000 | 95,442,008 | 19.12% | 0.00% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | A | Stock Option (Right to Buy) | 176550 | $0.00 | 176,550.0000 | 95,442,008 | 9999.99% | 0.18% |
| March 2, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | A | Restricted Stock Units | 35300 | $0.00 | 35,300.0000 | 95,442,008 | 9999.99% | 0.04% |
| March 3, 2026 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | M | Common Stock | 9409 | $0.00 | 16,409.0000 | 95,442,008 | 134.41% | 0.01% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | A | Restricted Stock Units | 37636 | $0.00 | 37,636.0000 | 81,484,950 | 9999.99% | 0.05% |
| March 3, 2025 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | A | Stock Option (Right to Buy) | 225814 | $0.00 | 225,814.0000 | 81,484,950 | 9999.99% | 0.28% |
| Sept. 27, 2024 | Viridian Therapeutics, Inc.\DE | $VRDN | Beetham Thomas W. | Chief Operating Officer | P | Common Stock | 5000 | $23.41 | 6,000.0000 | 0 | 500.00% | 0.00% |